About the Janssen Pharmaceutical Companies of Johnson & Johnson
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Learn more at www.janssen.com. Follow us at www.twitter.com/JanssenGlobal.
E-mail - firstname.lastname@example.org
E-mail - email@example.com
Latest Videos |view all videos
Dr. Merrick Ross provides an overview of the indications and logistics involved with sentinel lymph node biopsy as it relates to diagnosis and management of melanoma.
Evaluation of the Melanoma Patient for Other Primary Melanoma Lesions
Dr. Frederick Fish reviews the increased risk previously diagnosed melanoma patients face for developing new lesions while noting modalities that should be used to survey for new primary melanomas.
Neoadjuvant Therapy for Advanced Resectable Melanoma
Dr. Merrick Ross discusses immunotherapy as a modality to use prior to or in conjunction with surgery as a pathway to combat melanoma.
Dr. Merrick Ross outlines the expanding role of oncolytic immunotherapy in the treatment of melanoma.
Melanoma: Medical Legal Complications
Attorney Robert Cosgrove uses real life case scenarios to demonstrate when the diagnosis of melanoma had a legal impact.
Melanoma in the Molecular Age Part 2: New Tools for Diagnosis, Prognosis
Dr. Gregory Hosler expands upon Dr. Murphy’s lecture to further explore tools for diagnosis and prognosis of melanoma and applications to personalized medicine.